In efforts to promote the use of fixed-dose combinations (FDCs) for the treatment of tuberculosis (TB), the World Health Organization (WHO) and partners address the issue of quality assurance.
Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?
Department for Endemic Diseases Control, Prevention and Eradication, Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland. blomberg@who.ch
